小儿宝泰康颗粒辅助治疗小儿急性上呼吸道感染的临床疗效及安全性

Clinical Efficacy and Safety of Xiao'er Baotaikang Granules in Adjuvant Treatmentof Acute Upper Respiratory Tract Infection in Children

目的研究小儿宝泰康颗粒辅助治疗小儿急性上呼吸道感染的临床疗效及安全性。方法选取2021年5月-2023年4月在我院诊治的68例小儿急性上呼吸道感染患儿为研究对象,采用随机数字表法分为对照组和观察组,各组34例。对照组采用常规西药治疗,观察组在对照组基础上给予小儿宝泰康颗粒辅助治疗。比较两组临床疗效、临床症状(发热、咳嗽、鼻塞、流涕、咽喉肿痛)消失时间、炎症因子水平[C-反应蛋白(CRP)、白细胞介素-18(IL-18)、白细胞介素-6(IL-6)]及不良反应发生率。结果观察组治疗总有效率(94.12%)高于对照组(82.35%)(P<0.05);观察组发热、咳嗽、鼻塞、流涕、咽喉肿痛消失时间均短于对照组(P<0.05);两组CRP、IL-18、IL-6均低于治疗前,且观察组均低于对照组(P<0.05);观察组不良反应发生率与对照组比较,差异无统计学意义(P>0.05)。结论小儿宝泰康颗粒辅助治疗小儿急性上呼吸道感染临床疗效确切,可提高治疗效果,降低炎症因子水平,缩短临床症状消失时间,且不增加不良反应,具有良好的安全性、可行性,值得临床应用。

Objective To study the clinical efficacy and safety of Xiao'er Baotaikang granules in adjuvant treatment of acute upper respiratory tract infection in children.Methods A total of 68 children with acute upper respiratory tract infection diagnosed and treated in our hospital from May 2021 to April 2023 were selected as the research objects.They were divided into control group and observation group by random number table method,with 34 children in each group.The control group was treated with conventional western medicine,and the observation group was treated with Xiao'er Baotaikang granules on the basis of the control group.The clinical efficacy,disappearance time of clinical symptoms(fever,cough,nasal congestion,runny nose,sore throat),levels of inflammatory factors[C-reactive protein(CRP),interleukin-18(IL-18),interleukin-6(IL-6)]and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group(94.12%)was higher than that of the control group(82.35%)(P<0.05).The disappearance time of fever,cough,nasal congestion,runny nose and sore throat in the observation group was shorter than that in the control group(P<0.05).The levels of CRP,IL-18 and IL-6 in the two groups were lower than those before treatment,and those in the observation group were lower than those in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusion Xiao'er Baotaikang granules has a definite clinical effect in the adjuvant treatment of acute upper respiratory tract infection in children,which can improve the therapeutic effect,reduce the level of inflammatory factors,shorten the disappearance time of clinical symptoms,and does not increase adverse reactions.It has good safety and feasibility and is worthy of clinical application.